Where does Andy Weymann work?

Andy Weymann is Venture Partner, Frontiers in Health & Bio Investments at Verve Ventures and Chairman of Board at Becapio and Chairman at SolasCure.

What check size does Andy Weymann write?

Andy Weymann typically writes checks of $1.1M – $2.2M.

Where did Andy Weymann go to school?

Andy Weymann studied at Harvard Business School (Audit Committees in a New Era of Governance, Corporate Board Program); Harvard Business School (Compensation Committees: New Challenges, New Solutions); Harvard Business School (Making Corporate Boards More Effective, Cooperate Boards).

Andy Weymann

Investor

Venture Partner, Frontiers in Health & Bio Investments at Verve Ventures · Chairman of Board at Becapio · Chairman at SolasCure

Küssnacht am Rigi, Schwyz, Switzerland

Writes $1.1M – $2.2M checks

Find your path to Andy

685 people in our graph share verified history with Andy — schools, employers, funds. One of them is your warm intro.

Drew BurdonunlockedAndy: together at Smith+Nephew (2006–2018)

×10Andy: together at Harvard Business School

Andy: together at University of Rochester - Simon Business School

About

Andy Weymann, an MD/MBA with CMO and Global Head of Clinical Strategy experience including Smith & Nephew, bridges founders, regulators, clinicians and acquirers through C-suite, board and venture work.

Invests in

AI & Machine LearningClimate TechDeep TechHardwareHealthtechRobotics

Chairman of Board at Becapio

Intro paths

→

In turn, Andy can intro founders to Becapio's investors below.

Becapio's investors · 1

Trendlines GroupMisgav · $650K – $15M checks

Co-founders at Becapio

Dan LivovskyCo-Founder | Medical Director

Joseph LysyCo-Founder | Medical Director

Chairman at SolasCure

Intro paths

→

In turn, Andy can intro founders to SolasCure's investors below.

SolasCure's investors · 1

Seneca PartnersHaydock

Experience

BeCapioChairman of the Boardcurrent2024 — present
SolasCureChairman of the Boardcurrent2023 — presentCambridge, England, United Kingdom
GelmetixCEO and Director of the Boardcurrent2020 — presentManchester Area, United Kingdom
JellagenChairman of the Board of Directorscurrent2023 — presentCardiff, Wales, United Kingdom
VirtaMedDirector Board Of Directorscurrent2021 — presentZurich, Switzerland
Hyalex Orthopaedics Inc.Senior Medical Advisorcurrent2020 — present
30 TECHNOLOGYSenior Medical Advisorcurrent2020 — present
Smith& NephewChief Medical Officer and Senior Vice President Scientific, Clinical and Medical Affairs2012 — 2020Baar
Smith& NephewDirector Board Of Directors2019 — 2020
Smith& NephewDirector Board Of Directors2017 — 2020Baar, Zug, Switzerland
Smith& NephewVice President Medical Education Global2006 — 2012
AO FoundationManaging Director AO Education1997 — 2006
Spital DavosResident (orthopedics, trauma, sports medicine)1995 — 1997Davos
Schulthess Clinic ZurichResident (orthopedics)1994 — 1995Zurich, Switzerland

Skills & more

Non-Executive Director1Board Level3BiotechnologyMedical Devices99Orthopedic99Surgery91Medical Education63Healthcare53Product Launch50Hospitals44Clinical Research42Orthopedics43

+12 more

FDASports MedicineMarket DevelopmentBusiness StrategyClinical TrialsMarketing StrategyCommercializationCompetitive AnalysisLeadershipStrategic PlanningStrategyManagement

Languages English · French · German · Spanish

Advanced Coperate Director Seminar — Harvard Business School Executive Education

From Andy's professional profile.

Colleagues at Verve Ventures

Friederike Reinl

Partner, Head of Investor Relations at Verve Ventures

Lucas Laib

Partner, COO at Verve Ventures

Lukas Weber

Partner, CEO at Verve Ventures

Mike Hobmeier

Partner, Head Asset Management & Products at Verve Ventures

Romeo Bütler

Partner, CIO at Verve Ventures

Steffen Wagner

Partner, CEO at Verve Ventures

Thomas Meier

Partner, Head of Resilience in Energy & Resources Investments at Verve Ventures

Xavier Mesnier

Partner, Head of Frontiers in Health & Bio Investments at Verve Ventures

Frequently asked questions

Who is Andy Weymann?: Andy Weymann, an MD/MBA with CMO and Global Head of Clinical Strategy experience including Smith & Nephew, bridges founders, regulators, clinicians and acquirers through C-suite, board and venture work.
Where does Andy Weymann work?: Andy Weymann is Venture Partner, Frontiers in Health & Bio Investments at Verve Ventures and Chairman of Board at Becapio and Chairman at SolasCure.
What does Andy Weymann invest in?: Andy Weymann invests in AI & Machine Learning, Climate Tech, Deep Tech, Hardware, Healthtech, Robotics.
What check size does Andy Weymann write?: Andy Weymann typically writes checks of $1.1M – $2.2M.
Where did Andy Weymann go to school?: Andy Weymann studied at Harvard Business School (Audit Committees in a New Era of Governance, Corporate Board Program); Harvard Business School (Compensation Committees: New Challenges, New Solutions); Harvard Business School (Making Corporate Boards More Effective, Cooperate Boards).